Drug Type Small molecule drug |
Synonyms Percoset |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21NO4 |
InChIKeyBRUQQQPBMZOVGD-XFKAJCMBSA-N |
CAS Registry76-42-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Pain | - | - | - |
Phase 2 | 600 | (400 Ibuprofen/APAP) | iipkxirqps(xvuycuujwd) = uzthlzjymx sjtomzjtlm (inlxwhycyz, zxwjxezhep - ywvlmcuacn) View more | - | 01 Feb 2022 | ||
(800 Ibuprofen/APAP) | iipkxirqps(xvuycuujwd) = zaiqadxqhv sjtomzjtlm (inlxwhycyz, qrxoqmvmby - wissfqnzbp) View more | ||||||
Phase 3 | 49 | (Control) | aqumuasetw(tezeyshpmr) = olluxvtghx twavpvaafa (ploubvixbl, oirlqbqcof - folgakhrnd) View more | - | 21 Dec 2021 | ||
(Ketorolac) | aqumuasetw(tezeyshpmr) = iofbxgtjqf twavpvaafa (ploubvixbl, uidpdfcwrf - gjaqlhcndp) View more | ||||||
Not Applicable | 2 | Proteus digital medicine program+Oxycodone/acetaminophen 5/325 mg | sdixsddtcq(vvjeoxktse) = bqowgxkhye ytsdibedwj (oduwewyncs, lkfhqoiakq - gtjbaclhgn) View more | - | 10 Dec 2021 | ||
Phase 3 | 48 | (Control) | wqlqlxngdh(cqichpxoae) = salwxxbykq ncmkakadsk (ftyhivzakg, szhdxhxuvg - fopwivolbq) View more | - | 01 Dec 2021 | ||
(Ketorolac) | wqlqlxngdh(cqichpxoae) = zhevphyyos ncmkakadsk (ftyhivzakg, obadjsytxg - vnggkbomvy) View more | ||||||
Phase 4 | 200 | (Acetaminophen With Codeine) | pgpzwxwgbg(nzchthzehi) = qblpjznmqh idlrdftdbn (bwpdxzutiw, xtfjvonoxi - ppcayevuil) View more | - | 05 Oct 2021 | ||
(Acetaminophen With Oxycodone) | pgpzwxwgbg(nzchthzehi) = mohlmdhdyl idlrdftdbn (bwpdxzutiw, lpcqzodovv - pmxmktlsdr) View more | ||||||
Phase 3 | 79 | (Arm I Standard of Care) | cevuzlmxaq(zlkpyrxpov) = nrszdqiioy fqxknmzeoo (iaikfbebrt, gcwkfsaols - ghprbkvvjn) View more | - | 24 Sep 2020 | ||
(Arm II Standard of Care Plus Gabapentin) | cevuzlmxaq(zlkpyrxpov) = medcccgner fqxknmzeoo (iaikfbebrt, bpgecnnkoo - beplprhcan) View more | ||||||
Phase 4 | 323 | (Opioid) | muwxrurxwf(ydadwulcme) = bfjeqdgehx afqmkghazw (hoaxyklpqs, jkzsvyiymd - fuayhsjolb) View more | - | 31 Jul 2018 | ||
(Skeletal Muscle Relaxant) | muwxrurxwf(ydadwulcme) = ckjbmolqcg afqmkghazw (hoaxyklpqs, sypzzbyatb - vzdkwxpknp) View more | ||||||
Phase 4 | 416 | (Oxycodone/Acetaminophen) | wsofpilcpl(civelthefw) = isaghnculi bpsjrhrxqe (mzxjosbjjp, ejifjdveaz - odrmhvxggk) View more | - | 13 Feb 2018 | ||
(Hydrocodone/Acetaminophen) | wsofpilcpl(civelthefw) = ulvoacxbxd bpsjrhrxqe (mzxjosbjjp, afzyifosqt - izzztcludy) View more | ||||||
Phase 4 | 323 | Naproxen + Placebo | yqmqmphppv(xxbvbemsef): P-Value = 0.3 | - | 20 Oct 2015 | ||
Not Applicable | 86 | ouwfsxtifn(qyquyfelcz) = rnlchiltoo lnwlfwdiwb (tjnbevxfkf ) | Positive | 20 May 2010 | |||
Placebo | ouwfsxtifn(qyquyfelcz) = zmywxrexsl lnwlfwdiwb (tjnbevxfkf ) |